In 2023, the mortality rate due to malignant neoplasms in Canada stood at a baseline level. Forecasted data from 2024 to 2028 shows a gradual increase in female deaths, rising from 38.95 to 40 thousand. The year-on-year variation indicates a consistent upward trend of approximately 0.7% each year. Calculating the compound annual growth rate (CAGR) reveals an average growth of around 0.6% annually over these five years. This upward trajectory suggests a steady increase in mortality, highlighting potential public health challenges.
Future trends to monitor include advancements in cancer treatment technologies, early detection methods, and public health interventions aimed at reducing risk factors. These factors could pivotally influence mortality rates, altering current forecasts.
